Share-based Payment Arrangement, Expense of Tectonic Therapeutic, Inc. from 30 Sep 2017 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Tectonic Therapeutic, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Sep 2017 to 30 Sep 2025.
  • Tectonic Therapeutic, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $2,817,000, a 71% increase year-over-year.
  • Tectonic Therapeutic, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $8,625,000, a 1988% increase year-over-year.
  • Tectonic Therapeutic, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $3,491,000, a 211% increase from 2023.
  • Tectonic Therapeutic, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1,121,000, a 90% decline from 2022.
  • Tectonic Therapeutic, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $11,522,000, a 38% decline from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Tectonic Therapeutic, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $8,625,000 $2,817,000 +$1,167,000 +71% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $7,458,000 $2,588,000 +$2,185,000 +542% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $5,273,000 $2,103,000 +$1,782,000 +555% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $3,491,000 $1,117,000 +$3,078,000 01 Oct 2024 31 Dec 2024 10-K 20 Mar 2025 2024 FY
Q3 2024 $413,000 $1,650,000 +$1,375,000 +500% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 $962,000 $403,000 +$126,000 +45% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 $1,088,000 $321,000 -$2,209,000 -87% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $1,121,000 $1,961,000 -$4,215,000 -187% 01 Oct 2023 31 Dec 2023 10-K 20 Mar 2025 2024 FY
Q3 2023 $5,336,000 $275,000 -$2,381,000 -90% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $7,717,000 $277,000 -$2,957,000 -91% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2024 Q2
Q1 2023 $10,674,000 $2,530,000 -$848,000 -25% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $11,522,000 $2,254,000 -$1,830,000 -45% 01 Oct 2022 31 Dec 2022 10-K 14 Mar 2024 2023 FY
Q3 2022 $13,352,000 $2,656,000 -$2,513,000 -49% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $15,865,000 $3,234,000 -$1,457,000 -31% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 $17,322,000 $3,378,000 -$1,257,000 -27% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $18,579,000 $4,084,000 -$18,000 -0.44% 01 Oct 2021 31 Dec 2021 10-K 23 Mar 2023 2022 FY
Q3 2021 $18,597,000 $5,169,000 +$364,000 +7.6% 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022 2022 Q3
Q2 2021 $18,233,000 $4,691,000 +$792,000 +20% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022 2022 Q2
Q1 2021 $17,441,000 $4,635,000 +$1,813,000 +64% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q4 2020 $15,628,000 $4,102,000 +$2,217,000 +118% 01 Oct 2020 31 Dec 2020 10-K 17 Mar 2022 2021 FY
Q3 2020 $13,411,000 $4,805,000 +$3,008,000 +167% 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021 2021 Q3
Q2 2020 $10,403,000 $3,899,000 +$2,236,000 +134% 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021 2021 Q2
Q1 2020 $8,167,000 $2,822,000 +$1,367,000 +94% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q4 2019 $6,800,000 $1,885,000 +$805,000 +75% 01 Oct 2019 31 Dec 2019 10-K 18 Mar 2021 2020 FY
Q3 2019 $5,995,000 $1,797,000 +$1,247,000 +227% 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020 2020 Q3
Q2 2019 $4,748,000 $1,663,000 +$1,206,000 +264% 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020 2020 Q2
Q1 2019 $3,542,000 $1,455,000 +$1,346,000 +1235% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q4 2018 $2,196,000 $1,080,000 01 Oct 2018 31 Dec 2018 10-K 16 Mar 2020 2019 FY
Q3 2018 $550,000 +$504,000 +1096% 01 Jul 2018 30 Sep 2018 10-Q 07 Nov 2019 2019 Q3
Q2 2018 $457,000 01 Apr 2018 30 Jun 2018 10-Q 08 Aug 2019 2019 Q2
Q1 2018 $109,000 01 Jan 2018 31 Mar 2018 10-Q 13 May 2019 2019 Q1
Q3 2017 $46,000 24 Jun 2017 30 Sep 2017 10-Q 13 Nov 2018 2018 Q3

Tectonic Therapeutic, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $3,491,000 +$2,370,000 +211% 01 Jan 2024 31 Dec 2024 10-K 20 Mar 2025 2024 FY
2023 $1,121,000 -$10,401,000 -90% 01 Jan 2023 31 Dec 2023 10-K 20 Mar 2025 2024 FY
2022 $11,522,000 -$7,057,000 -38% 01 Jan 2022 31 Dec 2022 10-K 14 Mar 2024 2023 FY
2021 $18,579,000 +$2,951,000 +19% 01 Jan 2021 31 Dec 2021 10-K 23 Mar 2023 2022 FY
2020 $15,628,000 +$8,828,000 +130% 01 Jan 2020 31 Dec 2020 10-K 17 Mar 2022 2021 FY
2019 $6,800,000 +$4,604,000 +210% 01 Jan 2019 31 Dec 2019 10-K 18 Mar 2021 2020 FY
2018 $2,196,000 +$2,019,000 +1141% 01 Jan 2018 31 Dec 2018 10-K 16 Mar 2020 2019 FY
2017 $177,000 01 Jan 2017 31 Dec 2017 10-K 25 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.